Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
40 participants
INTERVENTIONAL
2018-08-28
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bedside Screening Method for Patients With Potential Swallowing Impairment
NCT01158313
Improving Diagnostic Standards in Dysphagia
NCT04773184
Validation and Clinical Application of Dysphagia Screening Questionnaire
NCT02838771
Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
NCT02959450
Dysphagia Symptom Severity and Quality of Life
NCT03241615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A modified textured diet and/or fluid is considered as an effective intervention in management of dysphagia. The International Dysphagia Diet Standardisation Initiative (IDDSI) have developed a new framework around the terms and descriptors used in the management of individuals with dysphagia. Malnutrition is very common in patients with dysphagia and the use of pre-thickened oral nutritional supplements (ONS) has been found as an effective way to manage this. However, due to impairment in the swallow process, dysphagic patients require pre-thickened oral nutritional supplement to ensure safe consumption of these nutritional supplements.
40 participants, requiring a new pre-thickened oral nutritional supplement in line with the new IDDSI framework recruited from hospitals, outpatients clinics, care homes, community hospitals, community dietetic/speech and language therapy services or stroke rehabilitation units will receive the ready-to-use oral nutritional supplement for a 4 week intervention period. This study aims to primarily evaluate gastro-intestinal tolerance, with secondary outcomes including compliance, acceptability, nutrient intake, anthropometry and safety.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IDDSI nutritional supplement drink
Single arm designed, 28day on IDDSI nutritional supplement drink
IDDSI nutritional supplement drink
ready-to-use nutritional supplement drink to be taken daily for 28 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IDDSI nutritional supplement drink
ready-to-use nutritional supplement drink to be taken daily for 28 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Patients with a requirement for ≥ 250kcal/day from a milkshake style ONS for ≥ 4 weeks or current users of ONS
* Patients identified to require mildly thick (IDDSI level 2) fluids.
* Patients competent to provide written informed consent and able to answer questions
* Patients able to take study ONS orally
Exclusion Criteria
* Patients that are unable to take study ONS orally
* Participants with chronic renal disease requiring dialysis
* Participants with liver failure
* Participants that are pregnant or lactating
* Participation in other studies that may interfere with this study
* Participants receiving 100% total nutritional requirements from tube feeding or parenteral nutrition
* Patients with galactosaemia or lactose intolerance
* Patients receiving palliative or end of life care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nutricia UK Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Stratton, Dr
Role: STUDY_DIRECTOR
Nutricia Ltd UK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aneurin Bevan University Health Board
Caerleon, , United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, , United Kingdom
Dudley Group NHS Trust
Dudley, , United Kingdom
Cwm Taf University Health Board
Llwynypia, , United Kingdom
Croydon Health NHS Trust
London, , United Kingdom
Lewisham and Greenwich NHS Foundation Trust
London, , United Kingdom
Great Western Hospitals NHS Foundation Trust
Swindon, , United Kingdom
Weston Area Health Trust
Weston-super-Mare, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDDSIL2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.